Publication details

Sledování aktivity CYP2D6 u pacientek s mentální bulimií (vliv na jídlení chování a sexuální aktivitu)

Title in English Bulimia Nervosa and CYP2D6 Activity (Influence on Eating Behaviour and Sexual Acitivty)
Authors

PALČÍKOVÁ Ivana ŽOURKOVÁ Alexandra VALENTOVÁ Daria

Year of publication 2007
Type Article in Periodical
Magazine / Source Česká a slovenská psychiatrie
MU Faculty or unit

Faculty of Medicine

Citation
Field Psychiatry, sexuology
Keywords bulimia; paroxetine; CYP2D6
Description Genetically conditioned change in activity of SSRI metabolizing enzymes may lead to different therapeutic response of patients, ranging from lack of efficacy to symptoms of toxicity and a significant incidence of drug-drug interactions. The activity of P 450 cytochromes can be determined by genotyping or phenotyping. CYP2D6, cytochrome P-450 isoenzyme, is a catalyzing enzyme of a number of frequently used SSRI and has been known to be genetically polymorphous. The goal of the study was to evaluate the efficacy of paroxetine treatment in female patients with mental bulimia (MB) while monitoring CYP2D6 activity
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info